Read this in The Manila Times digital edition.
(UPDATE) THE Food and Drug Administration (FDA) has launched "Task Force Fleming" to streamline the approval and evaluation process of Covid-19 drugs without compromising their quality and safety.
FDA Director-General Samuel Zacate said that there will no longer be the issuance of emergency use authorization (EUA), instead, Covid-19 drugs issued with certificates of product registration (CPR) will be made quickly available to the public under the supervision of Task Force Fleming.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.